{"name":"Biofabri, S.L","slug":"biofabri-s-l","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Instillation of IMUNO BCG Moreau RJ","genericName":"Instillation of IMUNO BCG Moreau RJ","slug":"instillation-of-imuno-bcg-moreau-rj","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Instillation of IMUNO BCG Moreau RJ","genericName":"Instillation of IMUNO BCG Moreau RJ","slug":"instillation-of-imuno-bcg-moreau-rj","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMioAJBVV95cUxPWEZyd1hOQzFxWFdET2NWN3NmaVRsZ09nVXI2R3ZDdTFfQUwwWGlZVXR1NlhncjMzRTBBYWpiejI1bHZHN1pTeTZoVi1uMkZyRVJZcUUtdXpGT3h3b3R2UmN6R1dBSFdRYnBLcjJmUl9kc2JYSkFfOG85cE5HeDFMNkVEenJDSF9HQXA5QTViSkkzLWUzRy1VVzVsdktoVlREOVRta3Y5VTZ1OThhMmhNQ2ExRVBlZUxTTnpOenVsdUNEUzhaUFZJMkxJel96VHVET3Nzamx0aUlTODdTa1luM2lpejVCOHIyLWNhOVE0amVsOXJILVUtbzU0bVNMUmJ6cFhVOXczal9ZTzlSWG5WQkV2a0JKbW1BbjdJZEoyemY?oc=5","date":"2025-01-22","type":"trial","source":"PR Newswire","summary":"Tuberculosis Clinical Trial Pipeline Appears Robust With 30+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - PR Newswire","headline":"Tuberculosis Clinical Trial Pipeline Appears Robust With 30+ Key Pharma Companies Actively Working in the Therapeutics S","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}